Preventing bleeding during myomectomy with misoprostol
Official title: Prevention of HEMOrhagic Risk in Upper MYOmeCTomy by Use of Misoprostol.
Run by University Hospital, Clermont-Ferrand · NCT06882824 · Data updated 2026-11-12
This will test whether giving misoprostol before myomectomy reduces surgical bleeding in women aged 18–43 having surgery for symptomatic uterine fibroids.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 43 Years |
| Sex | Women only |
| Enrollment | 80 (estimated) |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Locations | 1 site (Clermont-Ferrand, Clermont-Ferrand) |
| Status | Recruiting |
| Started | March 12, 2025 |
| Main results expected | April 17, 2027 |
| Study ends | April 17, 2028 |
| Registry record updated | September 24, 2025 |
| Trial ID | NCT06882824 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–43 with symptomatic uterine fibroids scheduled for laparoscopic or open myomectomy who meet the protocol size/number criteria, speak French, and are covered by a French social security scheme.
✕Probably not a fit
Patients on anticoagulants, with haemostatic disorders, pregnancy or breastfeeding, prior major uterine surgery, hepatic or renal insufficiency, or allergy to misoprostol are excluded and unlikely to receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional trial at CHU Clermont-Ferrand compares misoprostol versus placebo given before myomectomy to reduce intraoperative blood loss. Eligible women are 18–43 with symptomatic fibroids and an indication for laparoscopic or open myomectomy according to size and number criteria in the protocol. Participants receive misoprostol or placebo perioperatively and investigators record surgical blood loss, hemoglobin change, and transfusion needs. Key exclusions include anticoagulant use, bleeding disorders, prior major uterine surgery, pregnancy or hypersensitivity to misoprostol.
Why it matters
Potential benefit: If effective, misoprostol could lower intraoperative blood loss, reduce transfusion rates, and help patients recover faster after myomectomy.
How similar studies have gone: Small studies and clinical use of misoprostol for uterine contraction have suggested it may reduce surgical bleeding, but robust high-quality evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged 18 to 43 * Symptomatic myomas (bleeding, pain or infertility) * Indication for laparoscopic myomectomy Fibroma ≤ 10cm or number ≤ to 4 fibroids * Indication for myomectomy by laparotomy Fibroma \> 10cm, Number \> to 4 fibroids * OTAU possible intraoperatively (Clip on uterine artery and tourniquet placement) * Speak and understand French * Affiliated with a social security scheme. Exclusion Criteria: * History of major uterine surgery or myomectomy (excluding hysteroscopic myomectomy) * Allergy to misoprostol and lactose * Patients with hypersensitivity to misoprostol and/or other prostaglandins or to any of the product's excipients. * Patients taking aspirin or anti-coagulants * Patients with haemostasis disorders * Malnourished patients * Patients with hepatic or renal insufficiency * Pregnancy, suspected ectopic pregnancy and breast-feeding women. * Minors * Guardianship, curatorship, deprived of liberty, safeguard of justice
Where it's running
-
CHU Clermont-Ferrand
Clermont-Ferrand, Clermont-Ferrand, France Recruiting
Study contacts
- Principal investigator: Anne-Sophie GREMEAU — University Hospital, Clermont-Ferrand
- Study coordinator: Lise LACLAUTRE
- Email: promo_internet_drci@chu-clermontferrand.fr
- Phone: +33473754963
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Uterine artery ligation versus pericervical tourniquet to reduce bleeding during open myomectomy
This trial will test whether tying the uterine arteries or using a pericervical tourniquet better reduces blood loss during open myomectomy for women with symptomatic uterine fibroids.
-
Ergometrine versus carbetocin to reduce bleeding during abdominal myomectomy
This study will see if injecting ergometrine or carbetocin into the uterus during abdominal myomectomy reduces blood loss in women having surgery for symptomatic fibroids.
-
Bleeding control after single-ray amputation: Hemocoll vs Avitene vs bone wax
This trial tests whether Hemocoll, Avitene, or bone wax better stop bleeding from exposed bone after a planned single-ray amputation in adults.
-
Comparing periarticular vasoconstrictor infiltration and erector spinae plane block to reduce bleeding and pain in lumbar fusion
This trial will try periarticular vasoconstrictor infiltration versus erector spinae plane block to see if one reduces blood loss and postoperative pain in adults having lumbar fusion surgery.
-
Spraying low‑concentration lidocaine under the diaphragm to reduce shoulder pain after single‑port gynecologic laparoscopy
This will try spraying 0.08% lidocaine under the diaphragm at the start of single‑port laparoscopic surgery to see if it reduces immediate postoperative shoulder pain and improves mood for women having benign gynecologic operations.
-
Temporary Clamping of Uterine and Ovarian Vessels During Minimally Invasive Myomectomy
This study tests whether temporarily blocking blood flow from the uterine and ovarian arteries during minimally invasive myomectomy reduces blood loss for patients with large or multiple fibroids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.